2014 Q2 Form 10-Q Financial Statement
#000093976714000018 Filed on May 01, 2014
Income Statement
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q1 |
|---|---|---|---|
| Revenue | $6.562M | $4.905M | $9.669M |
| YoY Change | -44.65% | -49.27% | -47.76% |
| Cost Of Revenue | $477.0K | $309.0K | $280.0K |
| YoY Change | 67.37% | 10.36% | |
| Gross Profit | $6.085M | $4.596M | $9.389M |
| YoY Change | -47.41% | -51.05% | -49.28% |
| Gross Profit Margin | 92.73% | 93.7% | 97.1% |
| Selling, General & Admin | $16.47M | $14.69M | $10.55M |
| YoY Change | 24.93% | 39.32% | 33.48% |
| % of Gross Profit | 270.6% | 319.65% | 112.31% |
| Research & Development | $50.98M | $54.85M | $32.74M |
| YoY Change | 3.87% | 67.55% | -1.09% |
| % of Gross Profit | 837.73% | 1193.36% | 348.65% |
| Depreciation & Amortization | $600.0K | $498.0K | $842.0K |
| YoY Change | -25.0% | -40.86% | -31.71% |
| % of Gross Profit | 9.86% | 10.84% | 8.97% |
| Operating Expenses | $68.25M | $69.89M | $43.68M |
| YoY Change | 8.07% | 60.02% | 7.04% |
| Operating Profit | -$61.69M | -$64.99M | -$34.01M |
| YoY Change | 20.26% | 91.08% | 52.54% |
| Interest Expense | $12.08M | $11.76M | $11.06M |
| YoY Change | 7.49% | 6.38% | 176.15% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$11.72M | -$9.631M | -$10.72M |
| YoY Change | 7.88% | -10.15% | 178.85% |
| Pretax Income | -$73.40M | -$74.60M | -$44.73M |
| YoY Change | 18.08% | 66.78% | 71.11% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$73.41M | -$74.62M | -$44.73M |
| YoY Change | 18.1% | 66.82% | 71.04% |
| Net Earnings / Revenue | -1118.71% | -1521.28% | -462.6% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$376.6K | -$389.1K | -$243.3K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 194.7M shares | 194.6M shares | 183.7M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $233.5M | $273.6M | $356.6M |
| YoY Change | -33.66% | -23.28% | 46.51% |
| Cash & Equivalents | $147.3M | $157.5M | $171.2M |
| Short-Term Investments | $86.20M | $116.0M | $185.3M |
| Other Short-Term Assets | $17.00M | $17.60M | $23.20M |
| YoY Change | -6.08% | -24.14% | 404.35% |
| Inventory | $3.026M | $2.686M | $280.0K |
| Prepaid Expenses | |||
| Receivables | $5.000M | $4.500M | $3.900M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $258.6M | $298.3M | $383.9M |
| YoY Change | -31.04% | -22.3% | 53.58% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $4.052M | $4.685M | $5.786M |
| YoY Change | -28.28% | -19.03% | -20.74% |
| Goodwill | $63.68M | $63.68M | $63.68M |
| YoY Change | 0.0% | 0.0% | |
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $95.50M | $111.2M | $176.1M |
| YoY Change | -30.85% | -36.85% | 108.4% |
| Other Assets | $8.022M | $8.918M | $8.125M |
| YoY Change | 4.01% | 9.76% | 14.44% |
| Total Long-Term Assets | $182.1M | $199.3M | $275.6M |
| YoY Change | -23.23% | -27.7% | 69.48% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $258.6M | $298.3M | $383.9M |
| Total Long-Term Assets | $182.1M | $199.3M | $275.6M |
| Total Assets | $440.6M | $497.6M | $659.5M |
| YoY Change | -28.01% | -24.56% | 59.85% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $4.638M | $4.943M | $3.498M |
| YoY Change | 34.12% | 41.31% | 84.11% |
| Accrued Expenses | $41.37M | $39.12M | $21.26M |
| YoY Change | 40.68% | 83.97% | -41.59% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $95.28M | $1.392M | $12.86M |
| YoY Change | 659.48% | -89.17% | -8.16% |
| Total Short-Term Liabilities | $171.9M | $71.06M | $67.80M |
| YoY Change | 130.37% | 4.8% | -22.52% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $253.7M | $341.6M | $318.0M |
| YoY Change | -21.6% | 7.43% | 89.28% |
| Other Long-Term Liabilities | $5.102M | $5.467M | $6.113M |
| YoY Change | -13.26% | -10.57% | -75.25% |
| Total Long-Term Liabilities | $258.8M | $347.1M | $324.1M |
| YoY Change | -21.45% | 7.09% | 68.19% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $171.9M | $71.06M | $67.80M |
| Total Long-Term Liabilities | $258.8M | $347.1M | $324.1M |
| Total Liabilities | $437.4M | $426.1M | $404.7M |
| YoY Change | 5.21% | 5.29% | 44.37% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$1.647B | -$1.573B | -$1.299B |
| YoY Change | 21.01% | 21.15% | |
| Common Stock | $195.0K | $194.0K | $184.0K |
| YoY Change | 5.98% | 5.43% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $3.200M | $71.50M | $254.9M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $440.6M | $497.6M | $659.5M |
| YoY Change | -28.01% | -24.56% | 59.85% |
Cashflow Statement
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$73.41M | -$74.62M | -$44.73M |
| YoY Change | 18.1% | 66.82% | 71.04% |
| Depreciation, Depletion And Amortization | $600.0K | $498.0K | $842.0K |
| YoY Change | -25.0% | -40.86% | -31.71% |
| Cash From Operating Activities | -$55.30M | -$72.09M | -$54.42M |
| YoY Change | 38.25% | 32.47% | 263.59% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $100.0K | $384.0K | $729.0K |
| YoY Change | -114.29% | -47.33% | 912.5% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $44.70M | $60.70M | $67.10M |
| YoY Change | 3963.64% | -9.54% | -228.54% |
| Cash From Investing Activities | $44.60M | $60.36M | $66.35M |
| YoY Change | 11050.0% | -9.03% | -226.92% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $75.60M | $0.00 | |
| YoY Change | -100.0% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 400.0K | $65.29M | -$10.78M |
| YoY Change | 300.0% | -705.91% | -116.98% |
| NET CHANGE | |||
| Cash From Operating Activities | -55.30M | -$72.09M | -$54.42M |
| Cash From Investing Activities | 44.60M | $60.36M | $66.35M |
| Cash From Financing Activities | 400.0K | $65.29M | -$10.78M |
| Net Change In Cash | -10.30M | $53.56M | $1.163M |
| YoY Change | -73.92% | 4505.42% | -130.68% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$55.30M | -$72.09M | -$54.42M |
| Capital Expenditures | $100.0K | $384.0K | $729.0K |
| Free Cash Flow | -$55.40M | -$72.47M | -$55.14M |
| YoY Change | 40.97% | 31.42% | 266.7% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4943000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
9345000 | USD |
| CY2014Q1 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
8088000 | USD |
| CY2013Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
12797000 | USD |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
34958000 | USD |
| CY2014Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
39118000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
146000 | USD |
| CY2014Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
153000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1564670000 | USD |
| CY2014Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1644516000 | USD |
| CY2014Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3758000 | USD |
| CY2013Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2675000 | USD |
| CY2013Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
6314000 | USD |
| CY2014Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
6988000 | USD |
| CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
82611000 | shares |
| CY2013Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
73745000 | shares |
| CY2013Q4 | us-gaap |
Assets
Assets
|
503287000 | USD |
| CY2014Q1 | us-gaap |
Assets
Assets
|
497565000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
266609000 | USD |
| CY2014Q1 | us-gaap |
Assets Current
AssetsCurrent
|
298309000 | USD |
| CY2014Q1 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
407015000 | USD |
| CY2013Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
409966000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
407015000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
409966000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
406755000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
409721000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
39500000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
0 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
48420000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
358595000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
|
27 | investment |
| CY2014Q1 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
0 | investment |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
103978000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
157539000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
170069000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
171232000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1163000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
53561000 | USD |
| CY2014Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2186362 | shares |
| CY2014Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
194652943 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
184533651 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
184533651 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
194652943 | shares |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
184000 | USD |
| CY2014Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
194000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-44535000 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-74612000 | USD |
| CY2013Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
10000000 | USD |
| CY2014Q1 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
0 | USD |
| CY2014Q1 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
261408000 | USD |
| CY2013Q4 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
255147000 | USD |
| CY2014Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
309000 | USD |
| CY2013Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
280000 | USD |
| CY2013Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
| CY2014Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
2762000 | USD |
| CY2014Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1243000 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1450000 | USD |
| CY2013Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
842000 | USD |
| CY2014Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
498000 | USD |
| CY2014Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
1022000 | USD |
| CY2014Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.39 | |
| CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.24 | |
| CY2014Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1739000 | USD |
| CY2013Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
| CY2014Q1 | us-gaap |
Fiscal Period
FiscalPeriod
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exelixis adopted a 52- or 53-week fiscal year that generally ends on the Friday closest to December 31</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">st</sup></font><font style="font-family:inherit;font-size:10pt;">. Fiscal year 2013, a 52-week year, ended on December 27, 2013, and fiscal year 2014, a 53-week year, will end on January 2, 2015. For convenience, references in this report as of and for the fiscal quarters ended March 29, 2013 and March 28, 2014, and as of the fiscal year ended December 27, 2013, are indicated as ended March 31, 2013, March 31, 2014, and December 31, 2013, respectively.</font></div></div> | |
| CY2014Q1 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
0 | USD |
| CY2013Q1 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
0 | USD |
| CY2014Q1 | us-gaap |
Goodwill
Goodwill
|
63684000 | USD |
| CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
63684000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-4769000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-10254000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
4160000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-703000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-7110000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-207000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
280000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-204000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
5000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-229000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-143000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
1114000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
516000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
359000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4757000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
|
-6598000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
|
-6647000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
|
-2378000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
|
-1241000 | USD |
| CY2013Q1 | us-gaap |
Interest Expense
InterestExpense
|
11057000 | USD |
| CY2014Q1 | us-gaap |
Interest Expense
InterestExpense
|
11762000 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
81000 | USD |
| CY2014Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
343000 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
2890000 | USD |
| CY2014Q1 | us-gaap |
Inventory Net
InventoryNet
|
2686000 | USD |
| CY2014Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
678000 | USD |
| CY2013Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
529000 | USD |
| CY2014Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
1665000 | USD |
| CY2013Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2280000 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
437049000 | USD |
| CY2014Q1 | us-gaap |
Liabilities
Liabilities
|
426083000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
503287000 | USD |
| CY2014Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
497565000 | USD |
| CY2014Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
71056000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
87853000 | USD |
| CY2014Q1 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
1022000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
96157000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
384000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
729000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
504000 | USD |
| CY2014Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
343019000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
347237000 | USD |
| CY2014Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1392000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
11762000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
335475000 | USD |
| CY2014Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
341627000 | USD |
| CY2013Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
144299000 | USD |
| CY2014Q1 | us-gaap |
Long Term Investments
LongTermInvestments
|
111155000 | USD |
| CY2013Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
80328000 | USD |
| CY2014Q1 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
80219000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-10775000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
65287000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
60360000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
66353000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-72086000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-54415000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-44729000 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-74619000 | USD |
| CY2013Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-10719000 | USD |
| CY2014Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-9631000 | USD |
| CY2014Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
1392000 | USD |
| CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
1762000 | USD |
| CY2014Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment |
| CY2013Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
43679000 | USD |
| CY2014Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
69893000 | USD |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-34010000 | USD |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-64988000 | USD |
| CY2014Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
11974000 | USD |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
13116000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6888000 | USD |
| CY2014Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
8918000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
194000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
7000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
4674000 | USD |
| CY2014Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
5467000 | USD |
| CY2013Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-1733000 | USD |
| CY2014Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-1475000 | USD |
| CY2014Q1 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
2131000 | USD |
| CY2013Q1 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
338000 | USD |
| us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
36600000 | USD | |
| CY2014Q1 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
1409000 | USD |
| CY2013 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
6765000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
35937000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
504000 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
5386000 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
5112000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
75646000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
75600000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
-10479000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
-10791000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
90311000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
157096000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
276000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4910000 | USD |
| CY2014Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4685000 | USD |
| CY2013Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
3941000 | USD |
| CY2014Q1 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
4457000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
32735000 | USD |
| CY2014Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
54847000 | USD |
| CY2013Q4 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
12213000 | USD |
| CY2014Q1 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
12208000 | USD |
| CY2014Q1 | us-gaap |
Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
|
10814000 | USD |
| CY2013Q4 | us-gaap |
Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
|
16897000 | USD |
| CY2014Q1 | us-gaap |
Restructuring And Related Cost Expected Cost
RestructuringAndRelatedCostExpectedCost
|
2500000 | USD |
| CY2014Q1 | us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated Inception To Date
RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate
|
429 | employee |
| CY2013Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
119000 | USD |
| CY2014Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
46000 | USD |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
53300000 | USD | |
| CY2013 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1231000 | USD |
| CY2012Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
19222000 | USD |
| CY2014Q1 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
12231000 | USD |
| CY2013Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
13472000 | USD |
| CY2014Q1 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
-77000 | USD |
| CY2013 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
-311000 | USD |
| CY2014Q1 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
4298000 | USD |
| CY2013Q4 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
4425000 | USD |
| CY2013Q4 | us-gaap |
Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
|
9047000 | USD |
| CY2014Q1 | us-gaap |
Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
|
7933000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1498762000 | USD |
| CY2014Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1573381000 | USD |
| CY2014Q1 | us-gaap |
Revenues
Revenues
|
4905000 | USD |
| CY2013Q1 | us-gaap |
Revenues
Revenues
|
9669000 | USD |
| CY2014Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
4905000 | USD |
| CY2013Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
1856000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
14057195 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
7.12 | |
| CY2014Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
14691000 | USD |
| CY2013Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
10545000 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2679000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3758000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
352342 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
5979 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
626290 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
2000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
24232154 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
23983275 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.47 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.48 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
6.28 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
7.75 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.73 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
6.96 | |
| CY2014Q1 | us-gaap |
Share Price
SharePrice
|
8 | |
| CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
2000 | USD |
| CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y4M6D | |
| CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y5M15D | |
| CY2014Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
116033000 | USD |
| CY2013Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
138475000 | USD |
| CY2014Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
10000000 | shares |
| CY2014Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
19090 | shares |
| CY2014Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
71482000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
66238000 | USD |
| CY2014Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">The preparation of our consolidated financial statements is in conformity with accounting principles generally accepted in the United States which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to inventory, revenue recognition, valuation of long-lived assets, certain accrued liabilities including clinical trial accruals and restructuring liability, valuation of warrants, share-based compensation and the valuation of the debt and equity components of our convertible debt at issuance. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. </font><font style="font-family:inherit;font-size:10pt;">Actual results could differ materially from those estimates.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div> | |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
183742000 | shares |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
191699000 | shares |
| CY2013Q1 | exel |
Annual Operating Cycle
AnnualOperatingCycle
|
P364D | |
| CY2014Q1 | exel |
Annual Operating Cycle
AnnualOperatingCycle
|
P371D | |
| CY2014Q1 | exel |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
286000 | USD |
| CY2013Q4 | exel |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
300000 | USD |
| CY2014Q1 | exel |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
26000 | USD |
| CY2013Q4 | exel |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
55000 | USD |
| CY2014Q1 | exel |
Cash Cash Equivalentsand Availableforsale Securities
CashCashEquivalentsandAvailableforsaleSecurities
|
407749000 | USD |
| CY2013Q4 | exel |
Cash Cash Equivalentsand Availableforsale Securities
CashCashEquivalentsandAvailableforsaleSecurities
|
415862000 | USD |
| CY2013Q4 | exel |
Cash Cash Equivalentsand Availableforsale Securities Amortized Cost Basis
CashCashEquivalentsandAvailableforsaleSecuritiesAmortizedCostBasis
|
415617000 | USD |
| CY2014Q1 | exel |
Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Gain Accumulatedin Investments
CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedGainAccumulatedinInvestments
|
286000 | USD |
| CY2013Q4 | exel |
Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Gain Accumulatedin Investments
CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedGainAccumulatedinInvestments
|
300000 | USD |
| CY2014Q1 | exel |
Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Loss Accumulatedin Investments
CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedinInvestments
|
26000 | USD |
| CY2013Q4 | exel |
Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Loss Accumulatedin Investments
CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedinInvestments
|
55000 | USD |
| CY2014Q1 | exel |
Cash Cash Equivalentsand Availableforsale Securities Amortized Cost Basis
CashCashEquivalentsandAvailableforsaleSecuritiesAmortizedCostBasis
|
407489000 | USD |
| CY2014Q1 | exel |
Debt Collateral Number Of Affiliate Banks
DebtCollateralNumberOfAffiliateBanks
|
1 | affiliate |
| CY2014Q1 | exel |
Debt Collateral Number Of Required Investment Accounts
DebtCollateralNumberOfRequiredInvestmentAccounts
|
1 | account |
| CY2013Q1 | exel |
License Contractand Collaboration Reimbursement Revenue
LicenseContractandCollaborationReimbursementRevenue
|
7813000 | USD |
| CY2014Q1 | exel |
License Contractand Collaboration Reimbursement Revenue
LicenseContractandCollaborationReimbursementRevenue
|
0 | USD |
| exel |
Numberof Restructurings Implemented
NumberofRestructuringsImplemented
|
5 | restructuring | |
| CY2014Q1 | exel |
Numberof Trialsin Process
NumberofTrialsinProcess
|
6 | trial |
| CY2013Q1 | exel |
Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases
ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases
|
16000 | USD |
| CY2014Q1 | exel |
Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases
ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases
|
120000 | USD |
| exel |
Proceedsfrom Subtenants
ProceedsfromSubtenants
|
11300000 | USD | |
| CY2013Q1 | exel |
Restructuring Reserve Cash Settlement Netof Proceeds
RestructuringReserveCashSettlementNetofProceeds
|
2400000 | USD |
| CY2014Q1 | exel |
Restructuring Reserve Cash Settlement Netof Proceeds
RestructuringReserveCashSettlementNetofProceeds
|
1200000 | USD |
| CY2014Q1 | exel |
Restructuring Reserve Proceedsfrom Saleof Property Plantand Equipment
RestructuringReserveProceedsfromSaleofPropertyPlantandEquipment
|
199000 | USD |
| CY2013 | exel |
Restructuring Reserve Proceedsfrom Saleof Property Plantand Equipment
RestructuringReserveProceedsfromSaleofPropertyPlantandEquipment
|
95000 | USD |
| CY2014Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--01-02 | |
| CY2014Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2014Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-03-28 | |
| CY2014Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2014Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000939767 | |
| CY2014Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
194694949 | shares |
| CY2014Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
| CY2014Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
EXELIXIS, INC. | |
| CY2014Q1 | dei |
Trading Symbol
TradingSymbol
|
exel |
